Health Biotech Limited WHO-GMP
Health Biotech Limited
Health Biotech Limited Health Biotech Limited
Health Biotech Limited Health Biotech Limited

Health Biotech Limited
Home - Products - Oncology(Anti-Cancer-Injectables) - Cytosine Arabinoside Injection

Cytosine Arabinoside Injection

It is phosphorylated in the body to corresponding nucleotide, which inhibits DNA repair. Cytorabine is cell cycle specific and acts primarly during S phase. Its main use is to induce remission in acute leukemia.
Composition :100mg/1ml, 500mg/5ml, 1000mg/10ml
Indications :Acute leukemias, lymphosarcomas.
Dosage:3-6 mg/Kg body wt. i.v daily in 2 divided doses for 5-10 days.
Conraindications:Hypersensitivity, Pregnancy.
Special Precautions :Hepatic impairment.
Paediatrics : Indicated in certain leukemia, under strict supervision.
Pregnancy : Safety not established
Lactation : Safety not established
Elderly : Use with caution
Side- Effect :Bone marrow suppression. G.I.T disturbances.
Drug Interaction :Potentiates bone marrow depression with radiotheraphy and other myelotoxic drugs. Reduces plasma concentration of digoxin,antagonizes gentamycin. Decreased efficacy of flurocytosine.
Purity :Not less than 99%.
» Get an Instant Quote

Cytosine Arabinoside Injection
Ask for Price
Health Biotech Limited
Our Products
Oncology(Anti-Cancer-Injectables)  |   Pre-Filled Syringes  |   Anti-Infectives Injections   |   Liquid Ampoules / Vials  |   Biological Injections
Cardiovascular Injections  |   Neurology  |   Other Injectables  |   Hormones  |   Eye/ Ear/ Nasal Drops  |   Liquid Syrups, Dry Syrups & Redi-Mix Syrups  |   Pharmaceutical Capsules  |   Pharmaceutical Tablets  |   Tablets and Capsule  |   Green Tea Fat Burner

Clicky Web Analytics

Looking for Product Name ?